Share on StockTwits

Research Analysts’ upgrades for Thursday, August 21st:

Barclays (NYSE:BCS) was upgraded by analysts at Berenberg Bank to a hold rating.

BHP Billiton Limited (NYSE:BHP) was upgraded by analysts at S&P Equity Research to a buy rating.

CIT Group (NYSE:CIT) was upgraded by analysts at Morgan Stanley from a neutral rating to a positive rating. They currently have $48.00 price target on the stock, down from their previous price target of $50.00. The analysts wrote, “Two-thirds of OneWest’s loans in 2013 were higher-yielding legacy loans. As these rundown margins will be impacted by 50bps, we decrease our estimates to account for lower expected income from OneWest, lower our TP from $50 to $48, and maintain our Neutral rating.”

Eagle Materials (NYSE:EXP) was upgraded by analysts at Zacks from an underperform rating to a neutral rating. They currently have $99.30 target price on the stock.

Fortegra Financial Corp (NYSE:FRF) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $10.60 target price on the stock.

Assicurazioni Generali SpA (BIT:G) was upgraded by analysts at Deutsche Bank to a buy rating.

Gruma S.A.B. de C.V. (NYSE:GMK) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $50.20 target price on the stock.

Hewlett-Packard Company (NYSE:HPQ) was upgraded by analysts at FBN Securities from a sector perform rating to an outperform rating. FBN Securities currently has $45.00 target price on the stock, up from their previous target price of $35.00.

Kohl's Co. (NYSE:KSS) was upgraded by analysts at Gilford Securities from a neutral rating to a buy rating.

Mercadolibre (NASDAQ:MELI) was upgraded by analysts at Zacks from an underperform rating to an outperform rating. Zacks currently has $115.30 target price on the stock.

Randstad Holdings (EU:RSH) was upgraded by analysts at S&P Equity Research to a buy rating.

Sanofi (EU:SAN) was upgraded by analysts at S&P Equity Research to a buy rating.

Spectra Energy Partners, (NYSE:SEP) was upgraded by analysts at Zacks from an underperform rating to a neutral rating. They currently have $56.30 target price on the stock.

Siemens AG (FRA:SIE) was upgraded by analysts at S&P Equity Research to a buy rating.

Skullcandy (NASDAQ:SKUL) was upgraded by analysts at Davidson to a buy rating.

Symmetry Medical (NYSE:SMA) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $11.00 target price on the stock. Zacks’ analyst wrote, “We have upgraded our recommendation on Symmetry Medical to Outperform from Neutral. The company’s 2014-second quarter earnings surged 50.0% to $0.15 and beat the Zacks Consensus Estimate by 33.3%. Revenues of $101.3 million rose 2.3% and also surpassed the mark. The company’s decision to divest U.K. based Clamonta will benefit in the long-run but negatively affect 2014 earnings and revenues. The new high-margin Surgical business continues to face headwinds, but we believe that long-term prospects of this business are still intact. The recent decision to divest the OEM Solutions business is also expected to improve liquidity and enhance growth. We set a target of $11.00 on the stock.”

United Therapeutics (NASDAQ:UTHR) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $112.00 price target on the stock. Zacks’ analyst wrote, “United Therapeutics’ second quarter 2014 EPS was better than expected at $2.10. This was well above the Zacks Consensus Estimate of $1.66 and the year-ago EPS of $1.52. Revenues, which increased 15% to $322.8 million, surpassed the Zacks Consensus Estimate of $311 million. Revenues benefited from the continued uptake of existing products and the launch of Orenitram. The company remains well-positioned to gain share in the PAH market and estimates for 2014 and 2015 are on the rise following the strong second quarter performance. Based on these factors, we are upgrading United Therapeutics to Outperform.”

Walgreen Company (NYSE:WAG) was upgraded by analysts at Bank of America from an underperform rating to a neutral rating. Bank of America currently has $66.00 target price on the stock, up from their previous target price of $30.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Wincor Nixdorf (EU:WIN) was upgraded by analysts at Berenberg Bank to a buy rating.

Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with Analyst Ratings Network's FREE daily email newsletter.